Food/Recall·openFDA/food

Fayus Inc. — Class II: OLA-OLA POUNDED GROUNDNUTS (INTWILO) NET WT. 32 oz., 2 lbs. (0.907 kg) Distributed by: Yu

MediumPublished Jul 22, 2026· AI-analyzed Jul 27, 2026View original FDA source
AI-generated regulatory interpretation. The four sections below are an analyst-style summary produced by an AI model from the original FDA source. Always verify against the source before any regulatory, clinical, or commercial decision.
What happened

Fayus Inc. has initiated a Class II recall for OLA-OLA POUNDED GROUNDNUTS (INTWILO) due to undeclared peanuts. The products were distributed in 32 oz (2 lbs) packaging by Yusol International Foods.

Who it affects

This recall affects Fayus Inc., Yusol International Foods, and personnel involved in food labeling, allergen control, and supply chain management for nut-based products.

Why it matters

The recall underscores a critical failure in allergen labeling where the common name 'groundnuts' was used without the specific food allergen declaration for 'peanuts' required under U.S. regulations. For regulatory teams, this serves as a reminder that synonymous terms for allergens do not substitute for mandatory declaration requirements. The 'Ongoing' status suggests that market withdrawal and reconciliation activities are still being monitored by the FDA.

Practical takeaway

Quality teams should conduct a label-to-ingredient verification audit for all peanut-based products to ensure common names (e.g., groundnuts) and specific allergen declarations (e.g., peanuts) are both accurately represented. Distributors should confirm that current stock under UPC 650655764330 is isolated from distribution.

FDA source material

Class II. Reason: Undeclared peanuts. Product: OLA-OLA POUNDED GROUNDNUTS (INTWILO) NET WT. 32 oz., 2 lbs. (0.907 kg) Distributed by: Yusol International Foods Sacramento, CA 95828 Product of USA INGREDIENTS: Pounded Groundnuts (Intwilo) UPC: 650655764330. Firm: Fayus Inc. (Sacramento CA United States). Status: Ongoing.

Open in openFDA / FDA.gov
AI-generated interpretation. Always verify critical decisions against the original FDA source. Generated with google/gemini-3-flash-preview.